FLUTICASONE PROPIONATE / SALMETEROL (Seretide Evohaler®)

Clinical Indication

Asthma

Comments

Asthma: NOT RECOMMENDED IN ADULTS

50/25 – For children 4 years and over only when an aerosol device is required.

125/25 – For 12-17 year olds only when increased dose of ICS indicated and an aerosol device is required.

Must not be used for AIR or MART regimens

COPD: Not licensed

Date of classification

February 2026

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.